Hey, our new website is nearly completed and we'd love for you to take a look at it!

Yes, show me! No thanks!
Glucose Tolerance Factor Chroma-Cinn - 90 vegetable capsules

Glucose Tolerance Factor Chroma-Cinn

Product Code(s):
90084 – 90 vegetable capsules

Natural Product Number (NPN):


Product Brief:

Health First’s Glucose Tolerance Factor Chromium Chelavite provides support for healthy glucose metabolism, helps the body to metabolize carbohydrates and fats and helps to prevent chromium deficiency. GTF Chroma-Cinn contains a patented form of chromium, Chromium Chelavite. Chromium Chelavite is considered more absorbable than popular forms of chromium, such as chromium picolinate (57.5% vs. 37.5%). Chromium is known to support healthy glucose metabolism. GTF Chroma-Cinn also contains cinnamon extract. Several studies done on humans have shown that cinnamon is able to reduce glucose blood levels and increase insulin sensitivity, as well as lower LDL cholesterol levels.

GTF= Glucose Tolerance Factor. Chromium Chelavite is a trademark of Albion, Inc., USA.US Patent Nos. 5,292,729

Free from: artificial colours, artificial flavours, gluten, wheat, lactose, dairy, preservatives, soy, yeast and GMO materials.

Medicinal ingredients: Each capsule contains: Chromium (bisglycinate, nicotinate) chelate – 200 mcg Chromium Chelavite®; Cinnamon bark (Cinnamomum cassia) 10:1 extract, equivalent to 250 mg – 25 mg

Non-medicinal ingredients: Colloidal silicon dioxide, microcrystalline cellulose, magnesium stearate, hypromellose (capsule shell).


Adults (19 and over): Take 1 capsule twice daily between meals.

Risk information:

Consult a health care practitioner prior to use if you are pregnant or breastfeeding.

Keep out of the reach of children. Do not use if under cap safety seal is broken.

Manufactured exclusively for Health First® Network, Burlington, ON

SKU: 90084 Category:

Product Description



There are no reviews yet.

Be the first to review “Glucose Tolerance Factor Chroma-Cinn”

Your email address will not be published. Required fields are marked *